Lactose Intolerance Clinical Trial
Official title:
A Phase III, Non-Inferiority, Randomized, Blind, Parallel-Group, Multicentre, Multiple-Dose, Comparative Clinical Study of Lactase Eurofarma and Lactaid®, Assessing the Efficacy and Safety in the Treatment of Patients With Lactose Intolerance"
The primary objective is to determine the compared clinical efficacy of Lactase Eurofarma (test drug), showing non-inferiority to Lactaid® (comparative drug) in the supportive treatment of lactose intolerance and to assess the safety and tolerance of Lactase Eurofarma (test drug) in the supportive treatment of lactose intolerance.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05100719 -
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
|
N/A | |
Completed |
NCT02518295 -
β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion
|
N/A | |
Completed |
NCT00599859 -
Effects of Lactose on Fecal Microflora
|
N/A | |
Completed |
NCT02636413 -
Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance
|
Phase 4 | |
Completed |
NCT02406469 -
Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior
|
Phase 4 | |
Terminated |
NCT00247806 -
Prevalence of Lactose Intolerance Following Stem Cell Transplantation
|
Phase 1 | |
Completed |
NCT03814668 -
Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution
|
N/A | |
Completed |
NCT03860051 -
Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults.
|
||
Not yet recruiting |
NCT06107088 -
Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance
|
N/A | |
Completed |
NCT02703987 -
HYBRID: Hydrogen Breath Test in Lactose Digestion
|
N/A | |
Completed |
NCT00395954 -
Amount of Lactose Causing Symptoms in Lactose Intolerant People
|
Phase 0 | |
Completed |
NCT01593800 -
The Effect of Probiotics on Lactose Intolerance
|
N/A | |
Completed |
NCT04164394 -
Effect of I31 Probiotic on Lactose Intolerance
|
N/A | |
Recruiting |
NCT05668468 -
A Bifido Bacteria to Improve Lactose Digestion and Tolerance
|
N/A | |
Completed |
NCT03563846 -
Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects
|
Phase 1 | |
Recruiting |
NCT02085889 -
Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders
|
||
Completed |
NCT03597516 -
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
|
Phase 3 | |
Not yet recruiting |
NCT03563859 -
Evaluation of Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
|
Phase 3 | |
Completed |
NCT02171403 -
Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls
|
N/A | |
Completed |
NCT02902016 -
Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies
|
N/A |